Results 11 to 20 of about 243,892 (195)

Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids [PDF]

open access: yesNew England Journal of Medicine, 2012
The efficacy and side-effect profile of ulipristal acetate as compared with those of leuprolide acetate for the treatment of symptomatic uterine fibroids before surgery are unclear.In this double-blind noninferiority trial, we randomly assigned 307 patients with symptomatic fibroids and excessive uterine bleeding to receive 3 months of daily therapy ...
Donnez J1   +14 more
openaire   +3 more sources

Ulipristal acetate before high complexity endoscopic (hysteroscopic, laparoscopic) myomectomy – a mini-review

open access: yesMenopause Review, 2017
Uterine myomas (fibromas, leiomyomas) are the most common tumours in women, and their clinical signs and symptoms are presented by 25-40% of patients with these benign tumours.
Włodzimierz Baranowski
doaj   +2 more sources

The Cost-Effectiveness of Emergency Hormonal Contraception with Ulipristal Acetate versus Levonorgestrel for Minors in France. [PDF]

open access: yesPLoS ONE, 2015
ObjectiveTo evaluate the cost-effectiveness of ulipristal acetate and levonorgestrel in minors in France, and analyze whether it is worthwhile to provide ulipristal acetate to minors free of charge.MethodsThe cost-effectiveness of two emergency ...
Ramona Schmid
doaj   +2 more sources

The effect of ulipristal acetate treatment on symptomatic uterine fibroids within 12-months follow-up

open access: yesMenopause Review, 2014
Aim of the study: The purpose of the study was to monitor the effect of ulipristal acetate treatment on symptomatic uterine fibroids within 12-months follow-up.
Sławomir Woźniak   +6 more
doaj   +2 more sources

Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management

open access: yesClinicoEconomics and Outcomes Research, 2015
Bernice Tsoi,1,2 Gord Blackhouse,1,2 Simon Ferrazzi,3 Clare J Reade,4 Innie Chen,5,6 Ron Goeree1,2,7 1Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada; 2Programs for Assessment of Technology in Health (PATH)
Tsoi B   +5 more
doaj   +1 more source

Emergency contraception: potential role of ulipristal acetate

open access: yesInternational Journal of Women's Health, 2010
Kristina Gemzell-Danielsson, Chun-Xia MengDepartment of Women’s and Children’s Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, SwedenAbstract: Unintended pregnancy is a global reproductive health ...
Kristina Gemzell-Danielsson   +1 more
doaj   +1 more source

Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence

open access: yesInternational Journal of Women's Health, 2015
Alice Trefoux Bourdet, Dominique Luton, Martin Koskas Department of Obstetrics and Gynecology, Bichat University Hospital, Paris Diderot University, Paris, France Abstract: Uterine myoma is the most common benign uterine tumor in women of reproductive ...
Trefoux Bourdet A, Luton D, Koskas M
doaj   +1 more source

Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids

open access: yesDrug Design, Development and Therapy, 2014
Nicoletta Biglia,1 Silvestro Carinelli,2 Antonio Maiorana,3 Marta D'Alonzo,1 Giuseppe Lo Monte,4 Roberto Marci4 1Department of Obstetrics and Gynaecology, Mauriziano "Umberto I" Hospital, University of Turin, Turin, 2Department of Pathology,
Biglia N   +5 more
doaj   +2 more sources

Ulipristal Acetate in Emergency Contraception [PDF]

open access: yesCollegium antropologicum, 2014
Despite the widespread availability of highly effective methods of contraception, unintended pregnancy is common. Unplanned pregnancies have been linked to a range of health, social and economic consequences. Emergency contraception reduces risk of pregnancy after unprotected intercourse, and represents an opportunity to decrease number of unplanned ...
Šprem Goldštajn, Marina   +5 more
core   +6 more sources

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate. [PDF]

open access: yesHum Mol Genet, 2023
Precision medicine carries great potential for management of all tumor types. The aim of this retrospective study was to investigate if the two most common genetically distinct uterine fibroid subclasses, driven by aberrations in MED12 and HMGA2 genes ...
Kolterud Å   +14 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy